Latest News and Press Releases

The complaint alleges KBR misled investors about TRANSCOM’s concerns over HomeSafe’s contract performance, causing losses when the truth emerged.

Defendants allegedly hid Avantor’s weakening competitive position and lost accounts, leading to weak Q3 results, a $785M charge, and a 23% stock drop.

Allegedly, defendants misled investors about the completeness of Savara’s MOLBREEVI BLA, leading to an FDA refusal and a 31.7% stock drop on May 27, 2025.

The Complaint alleges KBR hid TRANSCOM’s concerns about HomeSafe’s contract performance while falsely assuring investors of continued partnership growth.

The Complaint alleges DexCom made unauthorized G6 and G7 design changes, overstated reliability, and downplayed resulting health and regulatory risks.

Allegedly, F5 concealed a major cyber breach exposing BIG-IP source code and vulnerabilities, leading to a 10.7% stock drop when disclosed.

Allegedly, CarMax misled investors about its growth outlook, later revealing weak results and rising loan losses, causing stock drops of 17% and 20%.

Allegedly, defendants misled investors about Fly-E’s revenue outlook and battery risks, causing an 87% stock drop after revealing sharp sales declines.

Allegedly, defendants misled investors about the completeness of Savara’s MOLBREEVI BLA, leading to an FDA refusal and a 31% stock drop.

Allegedly, defendants overstated Dow’s resilience to economic pressures and dividend strength while downplaying sales declines and product oversupply.